美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Five Prime Therapeutics Inc.

38.00

0.0000

成交量：- -

成交额：- -

市值：17.41亿

市盈率：-16.60

高：38.00

开：38.00

低：38.00

收：38.00

52周最高：38.90

52周最低：2.84

股本：4,580.27万

流通股本：2,567.83万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.2894

每股收益(LYR):-2.2894

净资产收益率：-40.58%

总资产收益率：-17.19%

市净率：6.57

市盈率(LYR):-16.60

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Five Prime Therapeutics Inc.

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.fiveprime.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Five Prime Therapeutics, Inc.于2001年12月根据特拉华州法律注册成立，是一家临床阶段的生物技术公司，致力于发现和开发新的蛋白质疗法。蛋白质治疗剂是阻断疾病过程中细胞外蛋白质或蛋白质片段产生抗体或药物，包括癌症和炎症性疾病。该公司没有批准用于商业销售的产品，到目前为止并没从产品销售中获取任何收入。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎国际,美股交易,港股交易,交易美股,股票信息,股价,美股行情,美股打新,港股打新,IPO打新,购买美股,全球投资","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/FPRX/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"FPRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FPRX\",,,,,undefined,":{"symbol":"FPRX","market":"US","secType":"STK","nameCN":"Five Prime Therapeutics Inc.","latestPrice":38,"timestamp":1618516800000,"preClose":38,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":25678289,"shares":45802740,"eps":-2.289406,"marketStatus":"停牌","change":0,"latestTime":"04-15 16:00:00 EDT","open":38,"high":38,"low":38,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.289406,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772010000000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1379476800000,"exchange":"NASDAQ","adjPreClose":38,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FPRX\",,,,,undefined,":{"symbol":"FPRX","floatShares":25678289,"roa":"-17.19%","roe":"-40.58%","lyrEps":-2.289406,"shares":45802740,"dividePrice":0,"high":38,"amplitude":0,"preClose":38,"low":38,"week52Low":2.84,"pbRate":"6.57","week52High":38.9,"institutionHeld":0,"latestPrice":38,"eps":-2.289406,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.289406,"open":38,"prevYearClose":17.01},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FPRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-03-22","symbol":"FPRX","fiscalQuarterEnding":"2020/12","expectedEps":-0.5,"name":null,"time":"盘后","type":"earning","dateTimestamp":1616385600000,"reportTimeType":"post","actualEps":-0.51},{"date":"2020-11-03","symbol":"FPRX","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":"2020/09","expectedEps":-0.61,"defaultRemindTime":1604394000000,"name":null,"time":"","dateTimestamp":1604379600000,"actualEps":null},{"market":"US","date":"2020-08-06","symbol":"FPRX","fiscalQuarterEnding":"2020/06","expectedEps":-0.7,"name":null,"time":"盘后","type":"earning","dateTimestamp":1596686400000,"reportTimeType":"post","actualEps":-0.48},{"date":"2020-05-07","symbol":"FPRX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2020/03","expectedEps":-0.68,"defaultRemindTime":1588881600000,"name":null,"time":"盘后","dateTimestamp":1588824000000,"actualEps":null},{"date":"2020-02-27","symbol":"FPRX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/12","expectedEps":-0.97,"defaultRemindTime":1582837200000,"name":null,"time":"盘后","dateTimestamp":1582779600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FPRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FPRX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FPRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FPRX","date":"2021-04-20","current":-16.598192,"percent":0.167737,"low":-39.720739,"twenty":-17.980669,"median":-2.106798,"eighty":2.206531,"high":5.32454,"avg":-7.014537,"sd":10.93998,"marketCap":1740504120},"quantilePoints":[{"date":"2021-02-26","current":-11.036653,"twenty":-20.265024,"median":-2.123907,"eighty":2.201664,"marketCap":1046638948},{"date":"2021-03-05","current":-18.019737,"twenty":-19.200834,"median":-2.115353,"eighty":2.204098,"marketCap":1708865700},{"date":"2021-03-12","current":-17.948606,"twenty":-18.685425,"median":-2.115353,"eighty":2.204098,"marketCap":1702120177},{"date":"2021-03-19","current":-17.859457,"twenty":-18.010253,"median":-2.106798,"eighty":2.206531,"marketCap":1693665931},{"date":"2021-03-26","current":-20.525633,"twenty":-18.004945,"median":-2.115353,"eighty":2.204098,"marketCap":1730885544},{"date":"2021-04-01","current":-20.460455,"twenty":-18.004945,"median":-2.115353,"eighty":2.204098,"marketCap":1725389215},{"date":"2021-04-09","current":-20.579948,"twenty":-17.980669,"median":-2.106798,"eighty":2.206531,"marketCap":1735465818},{"date":"2021-04-16","current":-20.639694,"twenty":-17.980669,"median":-2.106798,"eighty":2.206531,"marketCap":1740504120},{"date":"2021-04-20","current":-20.639694,"twenty":-17.980669,"median":-2.106798,"eighty":2.206531,"marketCap":1740504120}],"updateTime":1771966514372},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.fiveprime.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Five Prime Therapeutics, Inc.于2001年12月根据特拉华州法律注册成立，是一家临床阶段的生物技术公司，致力于发现和开发新的蛋白质疗法。蛋白质治疗剂是阻断疾病过程中细胞外蛋白质或蛋白质片段产生抗体或药物，包括癌症和炎症性疾病。该公司没有批准用于商业销售的产品，到目前为止并没从产品销售中获取任何收入。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.029825},{"month":2,"riseRate":0.5,"avgChangeRate":0.008899},{"month":3,"riseRate":0.5,"avgChangeRate":0.073012},{"month":4,"riseRate":0.375,"avgChangeRate":-0.002547},{"month":5,"riseRate":0.428571,"avgChangeRate":0.057349},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.013532},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.051986},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.060151},{"month":9,"riseRate":0.571429,"avgChangeRate":0.003402},{"month":10,"riseRate":0.5,"avgChangeRate":0.126945},{"month":11,"riseRate":0.625,"avgChangeRate":0.443167},{"month":12,"riseRate":0.5,"avgChangeRate":0.069749}],"exchange":"NASDAQ","name":"Five Prime Therapeutics Inc.","nameEN":"Five Prime Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"FPRX\",market:\"US\",,,undefined,":null}}